LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 20.15
(9.99%)
CNY 20.15
(9.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.89 Billion CNY | 4.17% |
| 2022 | 14.29 Billion CNY | 17.41% |
| 2021 | 12.17 Billion CNY | 87.99% |
| 2020 | 6.47 Billion CNY | 7.09% |
| 2019 | 6.04 Billion CNY | 18.26% |
| 2018 | 5.11 Billion CNY | 42.18% |
| 2017 | 3.59 Billion CNY | 21.37% |
| 2016 | 2.96 Billion CNY | 96.5% |
| 2015 | 1.5 Billion CNY | 4.47% |
| 2014 | 1.44 Billion CNY | 14.31% |
| 2013 | 1.26 Billion CNY | 43.11% |
| 2012 | 882.71 Million CNY | -3.3% |
| 2011 | 912.83 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 13.66 Billion CNY | 1.05% |
| 2024 Q2 | 13.52 Billion CNY | -1.41% |
| 2024 Q1 | 13.71 Billion CNY | -7.92% |
| 2023 Q4 | 14.89 Billion CNY | 5.84% |
| 2023 Q1 | 13.96 Billion CNY | -2.37% |
| 2023 Q2 | 13.63 Billion CNY | -2.35% |
| 2023 Q3 | 14.07 Billion CNY | 3.22% |
| 2023 FY | 14.89 Billion CNY | 4.17% |
| 2022 Q4 | 14.29 Billion CNY | 6.55% |
| 2022 Q3 | 13.41 Billion CNY | 3.6% |
| 2022 Q2 | 12.95 Billion CNY | 10.85% |
| 2022 Q1 | 11.68 Billion CNY | -4.05% |
| 2022 FY | 14.29 Billion CNY | 17.41% |
| 2021 Q2 | 9.24 Billion CNY | -1.15% |
| 2021 Q3 | 10.03 Billion CNY | 8.54% |
| 2021 Q4 | 12.17 Billion CNY | 21.41% |
| 2021 FY | 12.17 Billion CNY | 87.99% |
| 2021 Q1 | 9.34 Billion CNY | 44.32% |
| 2020 Q2 | 6.21 Billion CNY | -6.02% |
| 2020 Q3 | 6.2 Billion CNY | -0.18% |
| 2020 Q4 | 6.47 Billion CNY | 4.42% |
| 2020 FY | 6.47 Billion CNY | 7.09% |
| 2020 Q1 | 6.61 Billion CNY | 9.33% |
| 2019 Q3 | 5.63 Billion CNY | -1.57% |
| 2019 Q1 | 5.42 Billion CNY | 5.96% |
| 2019 Q2 | 5.72 Billion CNY | 5.66% |
| 2019 FY | 6.04 Billion CNY | 18.26% |
| 2019 Q4 | 6.04 Billion CNY | 7.32% |
| 2018 Q1 | 3.89 Billion CNY | 8.31% |
| 2018 Q4 | 5.11 Billion CNY | 13.68% |
| 2018 Q3 | 4.49 Billion CNY | 6.93% |
| 2018 Q2 | 4.2 Billion CNY | 7.99% |
| 2018 FY | 5.11 Billion CNY | 42.18% |
| 2017 Q4 | 3.59 Billion CNY | 7.05% |
| 2017 Q1 | 2.96 Billion CNY | -0.13% |
| 2017 Q2 | 3.14 Billion CNY | 6.32% |
| 2017 Q3 | 3.36 Billion CNY | 6.77% |
| 2017 FY | 3.59 Billion CNY | 21.37% |
| 2016 Q2 | 2.14 Billion CNY | 22.21% |
| 2016 Q4 | 2.96 Billion CNY | 19.81% |
| 2016 Q3 | 2.47 Billion CNY | 15.3% |
| 2016 Q1 | 1.75 Billion CNY | 16.39% |
| 2016 FY | 2.96 Billion CNY | 96.5% |
| 2015 Q4 | 1.5 Billion CNY | 9.84% |
| 2015 FY | 1.5 Billion CNY | 4.47% |
| 2015 Q1 | 1.39 Billion CNY | -3.63% |
| 2015 Q2 | 1.1 Billion CNY | -20.87% |
| 2015 Q3 | 1.37 Billion CNY | 24.72% |
| 2014 FY | 1.44 Billion CNY | 14.31% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | 1.41 Billion CNY | 0.0% |
| 2014 Q4 | 1.44 Billion CNY | 1.92% |
| 2013 FY | 1.26 Billion CNY | 43.11% |
| 2012 FY | 882.71 Million CNY | -3.3% |
| 2011 FY | 912.83 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 842.28 Million CNY | -1668.439% |
| Jointown Pharmaceutical Group Co., Ltd | 63.06 Billion CNY | 76.382% |
| Yifeng Pharmacy Chain Co., Ltd. | 13.68 Billion CNY | -8.808% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 7.1 Billion CNY | -109.664% |